Literature DB >> 28968749

Omics AnalySIs System for PRecision Oncology (OASISPRO): a web-based omics analysis tool for clinical phenotype prediction.

Kun-Hsing Yu1,2,3, Michael R Fitzpatrick4, Luke Pappas4, Warren Chan1, Jessica Kung4, Michael Snyder2.   

Abstract

SUMMARY: Precision oncology is an approach that accounts for individual differences to guide cancer management. Omics signatures have been shown to predict clinical traits for cancer patients. However, the vast amount of omics information poses an informatics challenge in systematically identifying patterns associated with health outcomes, and no general purpose data mining tool exists for physicians, medical researchers and citizen scientists without significant training in programming and bioinformatics. To bridge this gap, we built the Omics AnalySIs System for PRecision Oncology (OASISPRO), a web-based system to mine the quantitative omics information from The Cancer Genome Atlas (TCGA). This system effectively visualizes patients' clinical profiles, executes machine-learning algorithms of choice on the omics data and evaluates the prediction performance using held-out test sets. With this tool, we successfully identified genes strongly associated with tumor stage, and accurately predicted patients' survival outcomes in many cancer types, including adrenocortical carcinoma. By identifying the links between omics and clinical phenotypes, this system will facilitate omics studies on precision cancer medicine and contribute to establishing personalized cancer treatment plans.
AVAILABILITY AND IMPLEMENTATION: This web-based tool is available at http://tinyurl.com/oasispro; source codes are available at http://tinyurl.com/oasisproSourceCode. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online.
© The Author 2017. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Year:  2018        PMID: 28968749      PMCID: PMC5860203          DOI: 10.1093/bioinformatics/btx572

Source DB:  PubMed          Journal:  Bioinformatics        ISSN: 1367-4803            Impact factor:   6.937


  9 in total

1.  Preparing for precision medicine.

Authors:  Reza Mirnezami; Jeremy Nicholson; Ara Darzi
Journal:  N Engl J Med       Date:  2012-01-18       Impact factor: 91.245

Review 2.  Machine learning in bioinformatics.

Authors:  Pedro Larrañaga; Borja Calvo; Roberto Santana; Concha Bielza; Josu Galdiano; Iñaki Inza; José A Lozano; Rubén Armañanzas; Guzmán Santafé; Aritz Pérez; Victor Robles
Journal:  Brief Bioinform       Date:  2006-03       Impact factor: 11.622

3.  The precision medicine initiative: a new national effort.

Authors:  Euan A Ashley
Journal:  JAMA       Date:  2015-06-02       Impact factor: 56.272

4.  A new initiative on precision medicine.

Authors:  Francis S Collins; Harold Varmus
Journal:  N Engl J Med       Date:  2015-01-30       Impact factor: 91.245

5.  Cancer statistics, 2016.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2016-01-07       Impact factor: 508.702

Review 6.  Omics Profiling in Precision Oncology.

Authors:  Kun-Hsing Yu; Michael Snyder
Journal:  Mol Cell Proteomics       Date:  2016-04-20       Impact factor: 5.911

7.  An informatics-assisted label-free approach for personalized tissue membrane proteomics: case study on colorectal cancer.

Authors:  Chia-Li Han; Jinn-Shiun Chen; Err-Cheng Chan; Chien-Peng Wu; Kun-Hsing Yu; Kuei-Tien Chen; Chih-Chiang Tsou; Chia-Feng Tsai; Chih-Wei Chien; Yung-Bin Kuo; Pei-Yi Lin; Jau-Song Yu; Chuen Hsueh; Min-Chi Chen; Chung-Chuan Chan; Yu-Sun Chang; Yu-Ju Chen
Journal:  Mol Cell Proteomics       Date:  2011-01-05       Impact factor: 5.911

8.  An overview of the Hadoop/MapReduce/HBase framework and its current applications in bioinformatics.

Authors:  Ronald C Taylor
Journal:  BMC Bioinformatics       Date:  2010-12-21       Impact factor: 3.169

9.  Predicting Ovarian Cancer Patients' Clinical Response to Platinum-Based Chemotherapy by Their Tumor Proteomic Signatures.

Authors:  Kun-Hsing Yu; Douglas A Levine; Hui Zhang; Daniel W Chan; Zhen Zhang; Michael Snyder
Journal:  J Proteome Res       Date:  2016-07-08       Impact factor: 4.466

  9 in total
  5 in total

1.  Classifying non-small cell lung cancer types and transcriptomic subtypes using convolutional neural networks.

Authors:  Kun-Hsing Yu; Feiran Wang; Gerald J Berry; Christopher Ré; Russ B Altman; Michael Snyder; Isaac S Kohane
Journal:  J Am Med Inform Assoc       Date:  2020-05-01       Impact factor: 4.497

2.  Association of Omics Features with Histopathology Patterns in Lung Adenocarcinoma.

Authors:  Kun-Hsing Yu; Gerald J Berry; Daniel L Rubin; Christopher Ré; Russ B Altman; Michael Snyder
Journal:  Cell Syst       Date:  2017-11-15       Impact factor: 10.304

Review 3.  A survey and evaluation of Web-based tools/databases for variant analysis of TCGA data.

Authors:  Zhuo Zhang; Hao Li; Shuai Jiang; Ruijiang Li; Wanying Li; Hebing Chen; Xiaochen Bo
Journal:  Brief Bioinform       Date:  2019-07-19       Impact factor: 11.622

4.  Reproducible Machine Learning Methods for Lung Cancer Detection Using Computed Tomography Images: Algorithm Development and Validation.

Authors:  Kun-Hsing Yu; Tsung-Lu Michael Lee; Ming-Hsuan Yen; S C Kou; Bruce Rosen; Jung-Hsien Chiang; Isaac S Kohane
Journal:  J Med Internet Res       Date:  2020-08-05       Impact factor: 5.428

5.  Deciphering serous ovarian carcinoma histopathology and platinum response by convolutional neural networks.

Authors:  Kun-Hsing Yu; Vincent Hu; Feiran Wang; Ursula A Matulonis; George L Mutter; Jeffrey A Golden; Isaac S Kohane
Journal:  BMC Med       Date:  2020-08-18       Impact factor: 8.775

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.